Physician profile
Chandresh Duggal
NPI 1437110947
$5,576.05
in general payments reported to CMS, 2019-2025
36 companies · $1,509 in 2025
The $1,509 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $331 · 2020: $269 · 2021: $285 · 2022: $335 · 2023: $974 · 2024: $1,874 · 2025: $1,509.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,357.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,357.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $624.31 | 2023-2025 | Repatha, Repatha |
| Cardiovascular Systems INC. | $472.46 | 2019-2022 | |
| Medtronic, INC. | $467.88 | 2022-2025 | Corevalve Evolut R, Resolute Onyx, Hawkone |
| Astrazeneca Pharmaceuticals LP | $407.88 | 2024-2025 | Farxiga, Wainua |
| Novartis Pharmaceuticals Corporation | $384.26 | 2023-2025 | |
| E.R. Squibb & Sons, L.L.C. | $382.24 | 2023-2025 | Camzyos, Eliquis |
| Shockwave Medical, INC | $313.51 | 2023-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $307.43 | 2020-2025 | Lifevest |
| Kestra Medical Technology Services, INC. | $299.95 | 2024-2025 | Assure Wcd |
| Abiomed | $296.23 | 2019-2022 | |
| Penumbra, INC. | $157.58 | 2023-2025 | Penumbra System, Indigo System |
| Esperion Therapeutics, INC. | $141.33 | 2024-2025 | Nexletol |
| Novo Nordisk INC | $123.64 | 2024-2025 | Ozempic, Wegovy |
| Alnylam Pharmaceuticals INC. | $113.68 | 2024-2025 | Onpattro |
| Merck Sharp & Dohme LLC | $103.43 | 2023-2025 | Verquvo |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Impulse Dynamics (USA) INC. | $99.58 | 2024 | Optimizer |
| Janssen Pharmaceuticals, INC | $96.82 | 2021-2024 | Xarelto |
| Cvrx, INC. | $92.47 | 2024-2025 | Barostim Neo System |
| Pfizer INC. | $79.49 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $71.88 | 2024-2025 | Jardiance |
| Boston Scientific Corporation | $68.10 | 2019-2021 | |
| Kiniksa Pharmaceuticals International, Plc | $57.41 | 2024 | Arcalyst |
| Medtronic Vascular, INC. | $50.38 | 2019-2020 | |
| Cordis US Corp. | $47.92 | 2023-2024 | Mynx Venous Vcd, Mynxgrip |
| Itamar Medical INC | $36.04 | 2024 | Watchpatone |
| Edwards Lifesciences Corporation | $34.92 | 2023 | Sapien 3 Ultra Resilia |
| Livanova USA, INC. | $30.84 | 2021 | |
| Kiniksa Pharmaceuticals, LTD. | $28.32 | 2023 | Arcalyst |
| Bridgebio Pharma, INC. | $26.16 | 2025 | Attruby |
| Atricure, INC. | $25.57 | 2025 | Epi-Sense Guided Coagulation System With Visitrax, Atriclip Laa Exclusion System |
| Elutia, INC. | $25.40 | 2021-2022 | |
| Ge Healthcare | $25.18 | 2025 | |
| Scpharmaceuticals INC. | $22.23 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $21.84 | 2025 | |
| Acist Medical Systems, INC. | $20.28 | 2019 | |
| Baxter Healthcare | $19.41 | 2023 | Hillrom - Cardiac Ambulatory Monitor |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chandresh Duggal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.